NewslettersPulmonary Cell NewsJ&J Scraps Late-Stage RSV Vaccine in R&D Overhaul, Dropping Out of Race with GSK, PfizerBy Jamie Kang - April 5, 20230295The healthcare giant’s pharmaceutical unit Janssen announced the end of work on the adult respiratory syncytial virus vaccine program and the discontinuation of a pivotal Phase III trial.[Fierce Biotech]Press Release